Pelzl, Steffen
![](https://www.eahp.eu/sites/default/files/styles/speakers_thumb/public/10091e06-e607-4e54-8e70-e61d3e631218_1_201_a.jpeg?itok=wnUb8UD_)
Seminar Title:
Pharmacotherapy – COVID19 – Repurposed drugs and treatment (25th Anniversary EAHP Congress - Hospital Pharmacy 5.0 - the future of patient care (2021))
Affiliation:
SLK-Kliniken Heilbronn
Country:
Germany
Current Status, Position
Dr Steffen Pelzl is currently Chairman of the Department of Pharmacy at SLK-Kliniken Heilbronn.
Education
Dr Pelzl studied Pharmacy at Eberhard-Karls University Tuebingen and became licensed pharmacist in 1999. In 2005 he obtained a PhD in Transplantation Immunology at Ruprecht-Karls University Heidelberg for his work on the identification of highly sensitized kidney transplant recipients.
Research Area
Dr Pelzl's research focuses on rational pharmacotherapy and on pharmacoeconomics of cancer therapies.
Conflict of interest: none